Medical Lab division to drive Warnex

After obtaining rights to a colorectal cancer blood screening test in May, Warnex (TSX:WNX) is looking for additional products to license into its Medical Laboratories division as it seeks to become the “unique provider” of specialized diagnostic tests in Canada. “Our other divisions are coming out of the recession okay, and we getting busy.  But [...]

DiagnoCure restructures into 2 segments

DiagnoCure (TSX: CUR) has announced a reorganization into two business segments — an administrative headquarters in Quebec City to hold its patents and DiagnoCure Oncology Laboratories, its U.S. sales, marketing and service laboratory operations. As part of the realignment, CEO John Schafer will relocate to the U.S. to lead the commercialization of the Previstage GCC [...]

Dundee biotech outlook sees ‘ample room for upside’

While we were at the J.P. Morgan Healthcare Conference in San Francisco last week, Dundee Securities issued its latest biotech sector update. On the bright side, analyst David Martin writes that there are signs Biovail, Angiotech and QLT stocks are bouncing back – supported by new strategies and new products in development for each company. [...]

DiagnoCure’s one, two punch against cancer

There is much talk these days about personalized medicine, but John Schafer likes to call it personal diagnostics. “I’m not trying to use my (molecular) test to make a drug, although you can and pharmaceutical companies are doing that,” the CEO of DiagnoCure (TSX:CUR) says in an exclusive interview with biotuesdays.com. “What I am using [...]